Complete Guide to Levamisole Pharmacokinetics
Overview
Levamisole is a Imidazothiazole (Immunomodulant/Anthelmintic) used in the Immunology / Antiparasitic / Oncology (adjuvant) therapeutic area. It is indicated for Anthelmintic use and immunomodulatory research applications. Allometric PK simulator for levamisole, an oral imidazothiazole anthelmintic with historical immunomodulatory use. Two-compartment cross-species model for translational PK scaling.
Mechanism of Action
Levamisole exerts its pharmacological effect by targeting Helminth nicotinic acetylcholine receptors; pleiotropic immunomodulatory pathways. As a Imidazothiazole (Immunomodulant/Anthelmintic), it modulates this target to achieve therapeutic efficacy in Anthelmintic use and immunomodulatory research applications. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
This Population PK model for Levamisole characterizes the time-course of drug concentrations following Oral administration. Key parameters such as clearance (CL), volume of distribution (Vd), and absorption rate constant (Ka) define the drug's disposition. Use the interactive simulator below to explore these parameters in detail.
Dosing & Administration
Levamisole is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Immunology / Antiparasitic / Oncology (adjuvant) therapeutic area, for the treatment of Anthelmintic use and immunomodulatory research applications, understanding the pharmacokinetics of Levamisole is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Levamisole pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Levamisole PK Simulator
Explore Levamisole pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Levamisole?
The elimination half-life of Levamisole depends on patient-specific factors. Use our interactive Levamisole PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Levamisole administered?
Levamisole is administered via the Oral route. It is indicated for Anthelmintic use and immunomodulatory research applications. As a Imidazothiazole (Immunomodulant/Anthelmintic), dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Levamisole?
Key pharmacokinetic parameters for Levamisole include clearance (CL), volume of distribution (Vd), and elimination half-life. Our interactive simulator uses a Population PK model to characterize the pharmacokinetics of Levamisole.
Can I simulate Levamisole dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Levamisole PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.